Downloading...
Download

Biotech

9EMA Support of the Gods and Bounce to the HeavensI will keep this one simple. We are closing in on a major bullish breakout. As we approach the top of the larger daily flag, you can see the smaller time frame Flat top setup. Here is the beautiful part of this pattern in pattern play. we are sitting on Super strong support of the 9EMA, Its tight Its right! That 9 EMA will help push through the Flat top for a Flat top Breakout! AND THEN!!!!! Boom that Breakout power will push us through the Flag into the unknown ( $2?? $5??? $10??? $1M?????(lol)) All we need is a Catalyst!! OH DAMN we got um incoming!!! SEE you all on the moon!! Buy BUY BUY!!
ALong
by JaxelCap
Exicure Inc. P-Modeling Pt Z. The Cajun Ship of ObliterationWelcome Hyperspace Archaeologists, Come for the laughs, stay for the Art. ___________________ Find the "we are here" bubble. I am most likely wrong... Meh . Who cares. but what... if.. good enough for me! All in. #pewpeww __________________________________ Trade Taken: Entry Range is $2.38 - $2.45 Target $8.60 Hold until April 2021 Technical. One Cajun Ship nestled w/ Root-1-2-3-4-5 & Root-W-X-Y-X-Z TimeFrame: 1-Day. _____________________________ Failure is a necessary presupposition to success. Laugh with me into madness. Thanks for Pondering the Unknown with Me, Glitch420 *Disclaimer: If you seizure prone, turn the brightness all the way up for extra eye bleed. This is financial advice.
NASDAQ:XCURLong
by Glitch420
1
Next biotech stock to shoot up? Firdapse Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020 Firdapse MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020 Short Float = 13.23% Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside Gain. Cloud turned bullish and 9 EMA crossed 21 in an upside fashion. **'*** This is not a recommendation for entering a position, please do your own Due dillligence ******
NASDAQ:CPRXLong
by Charlestrad3r
3
Photocure $PHO.OL trade above last major resistance on US patentPatent covering the use of Blue Light Cystoscopy (BLC®) with Hexvix as neoadjuvant* therapy in the treatment of bladder cancer in patients who are scheduled for a cystectomy. Early stage study results have shown an antitumor effect and induced systemic immune effects of hexaminolevulinate (HAL) and blue light in an orthotopic model of rat bladder cancer. Photocure has the intention to further investigate Hexvix for its therapeutic effect and the patent is a result of Photocure’s continued focus on securing intellectual property rights for its research results and pipeline activities. The patent was issued on 11 February 2020 and will expire in December 2036. * Neoadjuvant therapy: treatment (such as chemotherapy) administered before primary cancer treatment (such as surgery) to enhance the outcome of primary treatment Photocure OSL:PHO IR news release: photocure.com
OSL:PHOLong
by savepiginvest
Ladies and Fellas Start your Engines!!!We are ready!!! The presentation today will create the catalyst needed for Greatness and Glory!!! We have put up with that Bear crap for the last time, now lets make us some millionaires and cure some F**kin Cancer!! Notes: OBV: About to Break through top of its Trend! -Chart shows a slightly modified(Accelerated) Price projection. -Coming out a strong accumulation phase. -Continuation of Longer term Cup and Handle. Buy Buy Buy Let me know your Thoughts!!!
ALong
by JaxelCap
Curls for the Girls!! Breakout imminent!!Its been a while since I have published anything but this stock is ready for greatness and glory!! With upcoming news on the horizon ( presentation coming up) and a lot of speculation on potential Merck acquisition. The TA combined is ready to rocket!!! Notes: -200, 50, 20, and 9 EMA all curling right under the price(Curls for the girls).. This indicates a Strong level of support and momentum coming into play. -The Curls for the Girls is the powerhouse setup needed for breaking through this Bullish pennant. I hope you all buy now before I buy it all up!!! Good Luck. Let me know your Thoughts!
ALong
by JaxelCap
Dip buy with a coronaThe Beijing branch of China’s National Health Commission said a combination of lopinavir and ritonavir, sold under the brand name Kaletra by AbbVie, is part of its latest treatment plan for patients infected by the Coronavirus, which has killed at 81 people in China and sickened more than 2,800 worldwide. After breaking out of the downtrend, ABBV is coming back to retest the channel, support area and weekly 50 moving average. In terms of valuation, ABBV is currently trading at a Forward P/E ratio of 9. For comparison, its industry has an average Forward P/E of 15.48, which means ABBV is trading at a discount to the group. ABBV will be looking to display strength as it nears its next earnings release, which is expected to be February 7, 2020. In that report, analysts expect ABBV to post earnings of $2.20 per share. This would mark year-over-year growth of 15.79%
NYSE:ABBVLong
by Charlestrad3r
ABBV should soon find support for a bounceAbbvie has been falling hard on news that it will sell off some drug patents in order to win approval for its merger with Allergan. It is entering a support zone between about $77 and $81, however, and it may start to climb from here as investors start to get excited about the merger. Also look for Coronavirus news to move the stock; word on the street is that one of Abbvie's drugs is being used off-label to treat Coronavirus patients. With a 5.67% dividend yield and a forward P/E under 10, ABBV looks attractively valued. True, the patent sales will probably negatively affect that forward P/E, and the merger might ultimately result in a lower dividend yield. But Abbvie will also pocket a bunch of cash from those drug sales that can be used to grow its pipeline, and Allergan's forward P/E is also low, with plenty of potential upside.
NYSE:ABBVLong
by ChristopherCarrollSmith
2
Re-Evaluated Falling Wedge, still BullishI reevaluated the falling wedge and it occurred to me. This was was a failed wedge that created a new falling wedge ( Note Dark Gray lines vs. White lines). Here are my latest notes: -The Last 2 days have show a strong support around $ 0.77 which is also the 50 day MA. -Stochastic: Showing a strong Divergence as well as being oversold. -On Balance Volume: Still trending upward and holding its positive volume through the last couple weeks price decrease ( Serious bullish signal). -This may not cure the Coronavirus, but HELLO it could Cure CANCER!!! Last time I checked People hated cancer more than the Coronavirus( Sorry for the rant) We are still need a catalyst (News!!!!), But patience is a rough thing for most ( I mean hell I have ADHD, but I haven't left yet). Holding strong, Bullish as F**K, and Remember BUY BUY BUY!!! If you like my analysis follow me! If you have an opinion, Please let me know!! Multiple Opinions are better than one! I may not always be right but even when I am wrong I do it with Style!
ALong
by JaxelCap
1
Buckle up! Falling Wedge pattern on Daily Ready to Rocket!Perfect close yesterday to bounce off support into a major move up! This is what we have been waiting for! Notes: -Stochastic: is sitting in a good spot: Neutral ( Not oversold or Over bought) -On Balance Volume: Still trending up on the daily very strong sign, especially with the price decline in the short term, The OBV hints at strong momentum still. -Falling Wedge: Setup is perfect. Its very clean and we are in a good spot! -20 MA: to 20 moving average is a great support and sets up for a larger stronger bounce after a deep pullback like this. -SSR in place today so Bulls can really have an advantage here! -Pre Market: Off to a hot start! Good Luck and Buy Buy Buy!!!!
ALong
by JaxelCap